Terms: = Pancreatic cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
1264 results:
1. Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein.
Wu T; Yang H; Li J; Fang H; Shi X; Li J; Feng L
PLoS One; 2024; 19(4):e0299920. PubMed ID: 38630658
[TBL] [Abstract] [Full Text] [Related]
2. Protein Arginine Methyltransferases in pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy.
Bhandari K; Ding WQ
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612768
[TBL] [Abstract] [Full Text] [Related]
3. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer.
Luo Z; Chen Y; Chen B; Zhao Z; Wu R; Ren J
BMC Med Genomics; 2024 Apr; 17(1):82. PubMed ID: 38581025
[TBL] [Abstract] [Full Text] [Related]
4. STAT3 is a genetic modifier of TGF-beta induced emt in KRAS mutant pancreatic cancer.
D'Amico S; Kirillov V; Petrenko O; Reich NC
Elife; 2024 Apr; 13():. PubMed ID: 38573819
[TBL] [Abstract] [Full Text] [Related]
5. Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via activation of LOXL2.
Kim HS; Lee YS; Dong SM; Kim HJ; Lee DE; Kang HW; Kim MJ; Park JS
Oncol Res; 2024; 32(4):615-624. PubMed ID: 38560567
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA
Wei Y; Zhu P
Acta Pharm; 2024 Mar; 74(1):131-147. PubMed ID: 38554384
[TBL] [Abstract] [Full Text] [Related]
7. PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC.
Farina A; Tartaglione S; Preziosi A; Mancini P; Angeloni A; Anastasi E
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542466
[TBL] [Abstract] [Full Text] [Related]
8. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
9. FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition.
Liu E; Qian X; He Y; Chen K
Cell Cycle; 2024 Jan; 23(2):218-231. PubMed ID: 38466946
[TBL] [Abstract] [Full Text] [Related]
10. The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes.
Ye Z; Li Q; Hu Y; Hu H; Xu J; Guo M; Zhang W; Lou X; Wang Y; Gao H; Jing D; Fan G; Qin Y; Zhang Y; Chen X; Chen J; Xu X; Yu X; Liu M; Ji S
Cancer Lett; 2024 Apr; 588():216769. PubMed ID: 38438098
[TBL] [Abstract] [Full Text] [Related]
11. Sense and anti-sense: Role of FAM83A and FAM83A-AS1 in Wnt, EGFR, PI3K, emt pathways and tumor progression.
Zhao C; Li X; Zhang R; Lyu H; Xiao S; Guo D; Ali DW; Michalak M; Chen XZ; Zhou C; Tang J
Biomed Pharmacother; 2024 Apr; 173():116372. PubMed ID: 38432129
[TBL] [Abstract] [Full Text] [Related]
12. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
Gene; 2024 May; 908():148304. PubMed ID: 38387708
[TBL] [Abstract] [Full Text] [Related]
14. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma.
Joseph AM; Al Aiyan A; Al-Ramadi B; Singh SK; Kishore U
Front Immunol; 2024; 15():1323198. PubMed ID: 38384463
[TBL] [Abstract] [Full Text] [Related]
15. Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells.
Kaçaroğlu D; Yaylacı S; Gurbuz N
Cancer Med; 2024 Jan; 13(2):e6964. PubMed ID: 38379331
[TBL] [Abstract] [Full Text] [Related]
16. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma.
Kim IK; Diamond MS; Yuan S; Kemp SB; Kahn BM; Li Q; Lin JH; Li J; Norgard RJ; Thomas SK; Merolle M; Katsuda T; Tobias JW; Baslan T; Politi K; Vonderheide RH; Stanger BZ
Nat Commun; 2024 Feb; 15(1):1532. PubMed ID: 38378697
[TBL] [Abstract] [Full Text] [Related]
17. Exosomal non-coding RNA: A new frontier in diagnosing and treating pancreatic cancer: A review.
Sha G; Zhang W; Jiang Z; Zhao Q; Wang D; Tang D
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130149. PubMed ID: 38365161
[TBL] [Abstract] [Full Text] [Related]
18. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma.
Cai X; Wang Z; Lin S; Chen H; Bu H
Phytomedicine; 2024 Apr; 126():155402. PubMed ID: 38350242
[TBL] [Abstract] [Full Text] [Related]
19. Satellite double-stranded RNA induces mesenchymal transition in pancreatic cancer by regulating alternative splicing.
Iwata T; Kishikawa T; Seimiya T; Notoya G; Suzuki T; Shibata C; Miyakawa Y; Odawara N; Funato K; Tanaka E; Yamagami M; Sekiba K; Otsuka M; Koike K; Fujishiro M
J Biol Chem; 2024 Mar; 300(3):105742. PubMed ID: 38346537
[TBL] [Abstract] [Full Text] [Related]
20. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
[TBL] [Abstract] [Full Text] [Related]
[Next]
